Saturna Capital Corp Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Saturna Capital Corp acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,655 shares of the company’s stock, valued at approximately $616,000.

A number of other hedge funds have also recently modified their holdings of the business. Empowered Funds LLC grew its position in shares of GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares during the period. Acadian Asset Management LLC bought a new stake in GE HealthCare Technologies during the first quarter worth about $259,000. Cresset Asset Management LLC boosted its stake in GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after acquiring an additional 865 shares in the last quarter. Jump Financial LLC grew its holdings in GE HealthCare Technologies by 317.6% in the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after purchasing an additional 21,396 shares during the period. Finally, Gamco Investors INC. ET AL increased its stake in shares of GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after purchasing an additional 320 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3%

GE HealthCare Technologies stock opened at $62.04 on Wednesday. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The business’s fifty day moving average is $63.66 and its 200 day moving average is $71.60. The stock has a market capitalization of $28.22 billion, a PE ratio of 14.84, a price-to-earnings-growth ratio of 1.71 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Insider Activity

In related news, CFO James Saccaro bought 3,310 shares of the business’s stock in a transaction on Friday, May 1st. The stock was acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Peter J. Arduini bought 4,169 shares of the business’s stock in a transaction on Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 21,847 shares of company stock valued at $1,361,355 over the last three months. Corporate insiders own 0.36% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. BMO Capital Markets assumed coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 target price for the company. Evercore set a $80.00 price target on GE HealthCare Technologies in a research note on Thursday, April 30th. Piper Sandler lowered their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. JPMorgan Chase & Co. dropped their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Finally, Jefferies Financial Group cut their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $76.41.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.